Teva Pharmaceutical Industries Ltd (TEVA)

TEVA (NYSE:Drugs)
$39.30
neg -0.34
-0.86%
Today's Range: 39.16 - 39.72 | TEVA Avg Daily Volume: 3,890,600
Last Update: 06/19/13 - 4:04 PM EDT
Volume: 2,834,418
YTD Performance: 6.16%
Open: $39.70
Previous Close: $39.64
52 Week Range: $36.63 - $42.83
Oustanding Shares: 852,000,000
Market Cap: 33,500,640,000
6-Month Chart
TheStreet Ratings Grade for TEVA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 9 9
Moderate Buy 1 1 1 1
Hold 14 14 14 14
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.16 2.16 2.21 2.21
Latest Dividend: 0.27
Latest Dividend Yield: 2.41%
Dividend Ex-Date: 05/16/13
Price Earnings Ratio: 17.48
Price Earnings Comparisons:
TEVA Sector Avg. S&P 500
17.48 19.60 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.83% 4.45% -25.50%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 0.46 0.13
Net Income -30.80 -0.05 -0.02
EPS -27.20 -0.02 -0.01
Earnings for TEVA:
EBITDA 5.89B
Revenue 20.32B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $1.20 $1.30 $5.04 $5.46
Number of Analysts 15 15 16 15
High Estimate $1.32 $1.33 $5.17 $5.94
Low Estimate $1.04 $1.27 $4.86 $4.86
Prior Year $1.28 $1.28 $5.35 $5.04
Growth Rate (Year over Year) -6.15% 1.41% -5.71% 8.32%
Update Chart
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

The Real Tech Boom Is Still Just Beginning

By

Roger Arnold

 | Apr 2, 2013 | 3:00 PM EDT

If you're overly cautious about biotech, you could incur some major opportunity costs.

bearishTeva downgraded at Wells

Mar 18, 2013 | 7:59 AM EDT

TEVA was downgraded from Outperform to Market Perform, Wells Fargo said. Company is facing increased competition and price erosion in the generic market. 

bearishTeva downgraded at Canaccord

Feb 8, 2013 | 7:44 AM EST

TEVA was downgraded to Hold, Canaccord Genuity said. $45 price target. Company turnaround is taking longer than expected. 

Morning Es Trading

By

Bob Byrne

 | Feb 7, 2013 | 8:28 AM EST

Until we see a session close below 1498.25, a near-term change in direction is unlikely.

The Real Tech Boom Is Just Beginning

By

Roger Arnold

 | Dec 26, 2012 | 3:00 PM EST

Keep an eye on M&A action in biotech.

bearishTeva estimates, target reduced at Credit Suisse

Dec 3, 2012 | 8:18 AM EST

Shares of TEVA now seen reaching $50, according to Credit Suisse. Estimates also cut, given the company's new guidance. Outperform rating. 

bearishTeva Pharmaceuticals downgraded at UBS

Dec 3, 2012 | 8:03 AM EST

TEVA was downgraded to Neutral from Buy, UBS said. $41 price target. Company's transition will take time. 

Israeli Shares to Nab on a Tumble

By

John Dorfman

 | Nov 26, 2012 | 10:00 AM EST

These are quality stocks, and they’d be sure to fall on a military escalation with Iran.

A Slew of Cheery Earnings

By

David Katz

 | Nov 2, 2012 | 8:30 AM EDT

Here's a quick roundup of earnings from stocks we've recommended. The news has been uniformly good.

Two Robust Defensive Plays to Consider

By

Bret Jensen

 | Oct 26, 2012 | 2:30 PM EDT

In the healthcare sector, TMO and TEVA are well positioned to ride out the market’s current volatility.

Columnist Conversation / Market Updates

Texas's power grid pours on the coal
By

Glenn Williams

 | Jun 19, 2013 | 8:36 PM EDT
Faced with a capacity shortfall and possible energy shortages, Texas power producers dusted off some old plants and put ...

Brazil Protests and the Bovespa
By

Ed Ponsi

 | Jun 19, 2013 | 6:18 PM EDT
News outlets are widely reporting that proposed transit fare hikes have been rolled back in Brazil as a result of protes...
See more »

Our Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.